Nanotechnology in Epilepsy Management
Summary
Nanotechnology offers transformative strategies for the diagnosis and treatment of epilepsy by leveraging materials at the scale of biological structures. Advances in nanoparticle design have enabled enhanced penetration of the blood–brain barrier, site-specific drug delivery and minimised systemic toxicity. Multifunctional nanocarriers combine imaging modalities with therapeutic payloads to achieve real-time monitoring of seizure foci and on-demand drug release. Implantable nanosensors and miniaturised stimulation devices provide high-resolution mapping of neuronal activity and feedback-controlled neuromodulation. Biodegradable polymers and stimuli-responsive materials further permit tailored release profiles and reduce long-term implantation risks. These innovations aim to address refractory epilepsy, improve patient quality of life and establish personalised treatment regimens, while ongoing work seeks to validate long-term safety, biocompatibility and scalable manufacture.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Nanotechnology in Epilepsy Management publication trend
The graph below shows the total number of articles in nanotechnology in epilepsy management across all publications each year (not limited to Nature Index journals).
Technical terms
Nanoparticle: A particle with at least one dimension between 1 and 100 nanometres, often used to deliver drugs or imaging agents.
Theranostics: An integrated approach combining diagnostic and therapeutic functions within a single nanomaterial platform.
Blood–brain barrier (BBB): A selective physiological interface that regulates passage of substances from the bloodstream into the central nervous system.
Surface-enhanced Raman scattering (SERS): An optical technique that amplifies Raman signals of molecules adsorbed on nanostructured metal surfaces for high-sensitivity detection.
Superparamagnetic iron oxide nanoparticle (SPION): Iron oxide particles exhibiting magnetic behaviour only in the presence of an external field, used for magnetic targeting and imaging contrast.
References
- Bioinorganic Materials for Imaging, Diagnosis and Therapy of Neurological Disease. Small Structures (2024).
- Nanotheranostics in epilepsy: A perspective for multimodal diagnosis and strategic management. Nano Select (2021).
- Fighting Epilepsy with Nanomedicines—Is This the Right Weapon?. Pharmaceutics (2023).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.